LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 27

Search options

  1. Article: Comparative Evaluation of Yield and Fruit Physico-Chemical Characteristics of Five Commercial Cultivars of Pomegranate Grown in Southeastern Italy in Two Consecutive Years

    Tarantino, Annalisa / Frabboni, Laura / Mazzeo, Andrea / Ferrara, Giuseppe / Disciglio, Grazia

    Horticulturae. 2022 June 03, v. 8, no. 6

    2022  

    Abstract: This study, conducted over two consecutive seasons (2018–2019), evaluates the yield and fruit physico-chemical traits of five commercial cultivars (‘Mollar’, ‘Dente di Cavallo’, ‘Acco’, ‘Jolly red’ and ‘Wonderful’) grown in the orchard at Foggia (Puglia ... ...

    Abstract This study, conducted over two consecutive seasons (2018–2019), evaluates the yield and fruit physico-chemical traits of five commercial cultivars (‘Mollar’, ‘Dente di Cavallo’, ‘Acco’, ‘Jolly red’ and ‘Wonderful’) grown in the orchard at Foggia (Puglia region, southeastern Italy). The results show significant variations among the investigated cultivars for many measured parameters; seasons also significantly affected some data. As an average of the years, both ‘Dente di Cavallo’ and ‘Wonderful’ significantly showed the highest numbers (16.8 and 15.2, respectively) and weights (9.3 Kg, respectively) of fruit per tree. ‘Jolly red’ had the highest percentage of edible portions (58.5%), the most intense red color in juice (a* value, 11.7), a light-red skin color (despite its name) (a* value, 31.1) and the smallest fruits (26.7% of diameter ≤ 80 mm). Total soluble solids of all cultivars were considerable above the minimum value (12 °Brix) required for commercial use. ‘Wonderful’ significantly presented the highest value of juice acidity (2.5 g citric acid 100 mL⁻¹) and the lowest MI value, and therefore it was classified as sour. Both ‘Dente di Cavallo’ and ‘Wonderful’ had significantly higher phenolic contents (591.0 and 519.1 mg 100 mL⁻¹, respectively) than the other cultivars, while ‘Dente di Cavallo’ significantly showed the highest antioxidant activity value (6.4 mmol TE 100 L⁻¹). The Stepwise Discriminant Analysis procedure allowed a significant differentiation among the cultivars. Correlation analysis showed a considerable relation among the different fruit traits. The present data are helpful in the selection of elite desirable pomegranate cultivars to be used for commercial production.
    Keywords acidity ; antioxidant activity ; citric acid ; color ; cultivars ; discriminant analysis ; fruits ; juices ; orchards ; pomegranates ; trees ; Italy
    Language English
    Dates of publication 2022-0603
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2813983-5
    ISSN 2311-7524
    ISSN 2311-7524
    DOI 10.3390/horticulturae8060497
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article ; Online: TRPA1 rare variants in chronic neuropathic and nociplastic pain patients.

    Marchi, Margherita / Salvi, Erika / Andelic, Mirna / Mehmeti, Elkadia / D'Amato, Ilaria / Cazzato, Daniele / Chiappori, Federica / Lombardi, Raffaella / Cartelli, Daniele / Devigili, Grazia / Dalla Bella, Eleonora / Gerrits, Monique / Almomani, Rowida / Malik, Rayaz A / Ślęczkowska, Milena / Mazzeo, Anna / Gentile, Luca / Dib-Hajj, Sulayman / Waxman, Stephen G /
    Faber, Catharina G / Vecchio, Eleonora / de Tommaso, Marina / Lauria, Giuseppe

    Pain

    2023  Volume 164, Issue 9, Page(s) 2048–2059

    MeSH term(s) Humans ; Neuralgia/genetics ; TRPA1 Cation Channel/genetics ; Chronic Pain
    Chemical Substances TRPA1 Cation Channel ; TRPA1 protein, human
    Language English
    Publishing date 2023-04-19
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 193153-2
    ISSN 1872-6623 ; 0304-3959
    ISSN (online) 1872-6623
    ISSN 0304-3959
    DOI 10.1097/j.pain.0000000000002905
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Incidental diagnosis of lung adenocarcinoma following coronavirus OC 43 severe pneumonia.

    Iadevaia, Carlo / Perrotta, Fabio / Mazzeo, Grazia / Cerqua, Francesco Saverio / Mazzarella, Gennaro / Guarino, Salvatore / Parrella, Roberto / Bianco, Andrea

    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

    2020  Volume 90, Issue 3

    Abstract: Viral infections are frequent among patients with thoracic malignancies prompted by dysregulation of innate and adaptative immune response. Clinical symptoms and radiological findings of both viral pneumonia and lung adenocarcinoma may overlap resulting ... ...

    Abstract Viral infections are frequent among patients with thoracic malignancies prompted by dysregulation of innate and adaptative immune response. Clinical symptoms and radiological findings of both viral pneumonia and lung adenocarcinoma may overlap resulting in diagnostic and clinical  challenges.We present the case of a women admitted to our department presenting with an acute manifestation of coronavirus OC43 pneumonia with underlying undiagnosed lung adenocarcinoma.
    MeSH term(s) Adenocarcinoma of Lung/complications ; Adenocarcinoma of Lung/diagnosis ; Adult ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/complications ; Coronavirus Infections/diagnosis ; Female ; Humans ; Incidental Findings ; Lung Neoplasms/complications ; Lung Neoplasms/diagnosis ; Pandemics ; Pneumonia, Viral/complications ; Pneumonia, Viral/diagnosis ; SARS-CoV-2 ; Tomography, X-Ray Computed
    Keywords covid19
    Language English
    Publishing date 2020-07-14
    Publishing country Italy
    Document type Case Reports ; Journal Article
    ZDB-ID 1160940-0
    ISSN 1122-0643 ; 1120-0391
    ISSN 1122-0643 ; 1120-0391
    DOI 10.4081/monaldi.2020.1313
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Incidental diagnosis of lung adenocarcinoma following coronavirus OC 43 severe pneumonia

    Carlo Iadevaia / Fabio Perrotta / Grazia Mazzeo / Francesco Saverio Cerqua / Gennaro Mazzarella / Salvatore Guarino / Roberto Parrella / Andrea Bianco

    Monaldi Archives for Chest Disease, Vol 90, Iss

    2020  Volume 3

    Abstract: Viral infections are frequent among patients with thoracic malignancies prompted by dysregulation of innate and adaptative immune response. Clinical symptoms and radiological findings of both viral pneumonia and lung adenocarcinoma may overlap resulting ... ...

    Abstract Viral infections are frequent among patients with thoracic malignancies prompted by dysregulation of innate and adaptative immune response. Clinical symptoms and radiological findings of both viral pneumonia and lung adenocarcinoma may overlap resulting in diagnostic and clinical challenges.We present the case of a women admitted to our department presenting with an acute manifestation of coronavirus OC43 pneumonia with underlying undiagnosed lung adenocarcinoma.
    Keywords Coronavirus OC43 ; lung adenocarcinoma ; NSCLC ; viral pneumonia ; acute respiratory failure ; Medicine ; R
    Language English
    Publishing date 2020-07-01T00:00:00Z
    Publisher PAGEPress Publications
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Correction to: COVID-19 and the elderly patients: insights into pathogenesis and clinical decision-making.

    Perrotta, Fabio / Corbi, Graziamaria / Mazzeo, Grazia / Boccia, Matilde / Aronne, Luigi / D'Agnano, Vito / Komici, Klara / Mazzarella, Gennaro / Parrella, Roberto / Bianco, Andrea

    Aging clinical and experimental research

    2020  Volume 32, Issue 9, Page(s) 1909

    Abstract: In the published article, the title was published incorrectly as COVID-19. ...

    Abstract In the published article, the title was published incorrectly as COVID-19.
    Keywords covid19
    Language English
    Publishing date 2020-09-09
    Publishing country Germany
    Document type Published Erratum
    ZDB-ID 2104785-6
    ISSN 1720-8319 ; 1594-0667
    ISSN (online) 1720-8319
    ISSN 1594-0667
    DOI 10.1007/s40520-020-01700-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Which impact for proton pump inhibitors in SARS-CoV-2 pneumonia.

    Mazzeo, Grazia / Aronne, Luigi / Mariniello, Domenica Francesca / Allocca, Valentino / Palma, Maria Ilaria / Cerqua, Francesco Saverio / Iadevaia, Carlo / Costigliola, Adriano / Parrella, Roberto / Bianco, Andrea / Covid Group, Vanvitelli/Monaldi

    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

    2021  Volume 91, Issue 4

    Abstract: Identification of risk factors for severe outcome of SARS-CoV-2 infection is an important issue in COVID-19 management. Much attention has been focused on comorbidities as well as drugs taken by patients. Usage of proton pump inhibitors (PPIs) appears to ...

    Abstract Identification of risk factors for severe outcome of SARS-CoV-2 infection is an important issue in COVID-19 management. Much attention has been focused on comorbidities as well as drugs taken by patients. Usage of proton pump inhibitors (PPIs) appears to potentially influence disease course. These drugs are known to reduce stomach acid and also modulate the immune system. Their use, prior to and during COVID-19 infection, seems to predispose to the development of more severe pneumonia and therefore to a greater risk of mortality. Instead, the use of histamine receptor 2 antagonists (H2RAs) seems to be associated with a better outcome in patients with COVID-19, in terms of symptoms, risk of intubation and death. As PPIs are essential for treatment of many disorders, usage of these drugs should be balanced considering the benefits and risk ratio, in order to guarantee their correct use for the necessary time. It remains to be clarified whether the detrimental effects, in terms of COVID-19 severe outcome, are due to PPIs or to the underlying disease for which they are administered. New controlled-randomized trials are required to better understand their impact in SARS-CoV-2 infections. *Vanvitelli/Monaldi COVID Group: Adriano Cristinziano, Carolina Delle Donne, Cecilia Calabrese, Fabio Perrotta, Filippo Scialò, Francesco Lassandro, Gennaro Mazzarella, Giorgio Paoli, Leonardo De Luca, Maria Galdo, Miriam Buonincontro, Roberta Cianci, Rosalba Donizzetti, Stefano Sanduzzi Zamparelli, Tullio Valente, Vito D'Agnano, Vittorio Bisogni.
    MeSH term(s) COVID-19 ; Humans ; Proton Pump Inhibitors/adverse effects ; Risk Factors ; SARS-CoV-2
    Chemical Substances Proton Pump Inhibitors
    Language English
    Publishing date 2021-10-19
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 1160940-0
    ISSN 1122-0643 ; 1120-0391
    ISSN 1122-0643 ; 1120-0391
    DOI 10.4081/monaldi.2021.1803
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Incidental diagnosis of lung adenocarcinoma following coronavirus OC 43 severe pneumonia

    Iadevaia, Carlo / Perrotta, Fabio / Mazzeo, Grazia / Cerqua, Francesco Saverio / Mazzarella, Gennaro / Guarino, Salvatore / Parrella, Roberto / Bianco, Andrea

    Monaldi arch. chest dis

    Abstract: Viral infections are frequent among patients with thoracic malignancies prompted by dysregulation of innate and adaptative immune response. Clinical symptoms and radiological findings of both viral pneumonia and lung adenocarcinoma may overlap resulting ... ...

    Abstract Viral infections are frequent among patients with thoracic malignancies prompted by dysregulation of innate and adaptative immune response. Clinical symptoms and radiological findings of both viral pneumonia and lung adenocarcinoma may overlap resulting in diagnostic and clinical challenges.We present the case of a women admitted to our department presenting with an acute manifestation of coronavirus OC43 pneumonia with underlying undiagnosed lung adenocarcinoma.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #646494
    Database COVID19

    Kategorien

  8. Article ; Online: COVID-19 and the elderly: insights into pathogenesis and clinical decision-making.

    Perrotta, Fabio / Corbi, Graziamaria / Mazzeo, Grazia / Boccia, Matilde / Aronne, Luigi / D'Agnano, Vito / Komici, Klara / Mazzarella, Gennaro / Parrella, Roberto / Bianco, Andrea

    Aging clinical and experimental research

    2020  Volume 32, Issue 8, Page(s) 1599–1608

    Abstract: The elderly may represent a specific cluster of high-risk patients for developing COVID-19 with rapidly progressive clinical deterioration. Indeed, in older individuals, immunosenescence and comorbid disorders are more likely to promote viral-induced ... ...

    Abstract The elderly may represent a specific cluster of high-risk patients for developing COVID-19 with rapidly progressive clinical deterioration. Indeed, in older individuals, immunosenescence and comorbid disorders are more likely to promote viral-induced cytokine storm resulting in life-threatening respiratory failure and multisystemic involvement. Early diagnosis and individualized therapeutic management should be developed for elderly subjects based on personal medical history and polypharmacotherapy. Our review examines the pathogenesis and clinical implications of ageing in COVID-19 patients; finally, we discuss the evidence and controversies in the management in the long-stay residential care homes and aspects of end-of-life care for elderly patients with COVID-19.
    MeSH term(s) Aged ; Aged, 80 and over ; Aging ; Betacoronavirus ; COVID-19 ; Clinical Decision-Making ; Coronavirus Infections ; Cytokines/immunology ; Humans ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2
    Chemical Substances Cytokines
    Keywords covid19
    Language English
    Publishing date 2020-06-16
    Publishing country Germany
    Document type Journal Article ; Review
    ZDB-ID 2104785-6
    ISSN 1720-8319 ; 1594-0667
    ISSN (online) 1720-8319
    ISSN 1594-0667
    DOI 10.1007/s40520-020-01631-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Which impact for proton pump inhibitors in SARS-COV-2 pneumonia

    Grazia Mazzeo / Luigi Aronne / Domenica Francesca Mariniello / Valentino Allocca / Maria Ilaria Palma / Francesco Saverio Cerqua / Carlo Iadevaia / Adriano Costigliola / Roberto Parrella / Andrea Bianco / Vanvitelli/Monaldi COVID Group

    Monaldi Archives for Chest Disease (2021)

    2021  

    Abstract: Identification of risk factors for severe outcome of Sars-Cov-2 infection is an important issue in COVID-19 management. Much attention has been focused on comorbidities as well as drugs taken by patients. Usage of proton pump inhibitors (PPIs) appears to ...

    Abstract Identification of risk factors for severe outcome of Sars-Cov-2 infection is an important issue in COVID-19 management. Much attention has been focused on comorbidities as well as drugs taken by patients. Usage of proton pump inhibitors (PPIs) appears to potentially influence disease course. These drugs are known to reduce stomach acid and also modulate the immune system. Their use, prior to and during COVID-19 infection, seems to predispose to the development of more severe pneumonia and therefore to a greater risk of mortality. Instead, the use of Histamine receptor 2 antagonists (H2RAs) seems to be associated with a better outcome in patients with COVID-19, in terms of symptoms, risk of intubation and death. As PPIs are essential for treatment of many disorders, usage of these drugs should be balanced considering the benefits and risk ratio, in order to guarantee their correct use for the necessary time. It remains to be clarified whether the detrimental effects, in terms of COVID19 severe outcome, are due to PPIs or to the underlying disease for which they are administered. New controlled-randomized trials are required to better understand their impact in SARS-COV-2 infections. *Vanvitelli/Monaldi COVID Group: Adriano Cristinziano, Carolina Delle Donne, Cecilia Calabrese, Fabio Perrotta, Filippo Scialò, Francesco Lassandro, Gennaro Mazzarella, Giorgio Paoli, Leonardo De Luca, Maria Galdo, Miriam Buonincontro, Roberta Cianci, Rosalba Donizzetti, Stefano Sanduzzi Zamparelli, Tullio Valente, Vito D’Agnano, Vittorio Bisogni
    Keywords COVID-19 ; SARS-CoV-2 ; proton pump inhibitors ; histamine receptor 2 antagonists ; pneumonia ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2021-10-01T00:00:00Z
    Publisher PAGEPress Publications
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article: COVID-19 and coagulative axis: review of emerging aspects in a novel disease.

    Boccia, Matilde / Aronne, Luigi / Celia, Benito / Mazzeo, Grazia / Ceparano, Maria / D'Agnano, Vito / Parrella, Roberto / Valente, Tullio / Bianco, Andrea / Perrotta, Fabio

    Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace

    2020  Volume 90, Issue 2

    Abstract: Latest evidences from literature suggest that SARS-CoV-2 disease 2019 (COVID-19) is commonly complicated with coagulopathy and that disseminated intravascular coagulation is present in the majority of deceased patients. Particularly, conventional ... ...

    Abstract Latest evidences from literature suggest that SARS-CoV-2 disease 2019 (COVID-19) is commonly complicated with coagulopathy and that disseminated intravascular coagulation is present in the majority of deceased patients. Particularly, conventional coagulation parameters appear to be significantly altered in patients with poor prognosis. A wide-ranging cross- talk between coagulative haemostasis and inflammation, as well as the activation of coagulation cascade during viral infections, are well established. Another important evidence which may explain coagulation disorders in COVID-19 is the increase of thrombus formation under conditions of hypoxia. Despite the exact pathophysiological mechanism of coronavirus-induced thromboembolism needs to be further investigated, this finding suggests that it is good practice to assess the risk of thrombosis in COVID-19 patients to improvethe clinical management in terms of anticoagulation therapy. Anticoagulants, mainly low-molecular-weight heparin (LMWH), should be tailored in patients meeting sepsis induced coagulopathy (SIC) criteria or with markedly elevated D-dimer. In this context, further studies are needed to optimise the decision making in therapeutic approach.
    MeSH term(s) Betacoronavirus/isolation & purification ; Blood Coagulation/physiology ; Blood Coagulation Disorders/blood ; Blood Coagulation Disorders/epidemiology ; Blood Coagulation Disorders/virology ; COVID-19 ; Coronavirus Infections/blood ; Coronavirus Infections/epidemiology ; Humans ; Pandemics ; Pneumonia, Viral/blood ; Pneumonia, Viral/epidemiology ; SARS-CoV-2
    Keywords covid19
    Language English
    Publishing date 2020-05-19
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 1160940-0
    ISSN 1122-0643 ; 1120-0391
    ISSN 1122-0643 ; 1120-0391
    DOI 10.4081/monaldi.2020.1300
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top